Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis

Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 40; no. 37; pp. 5639 - 5650
Main Authors Zhang, Ming-xiao, Zhang, Li-zhen, Fu, Liang-min, Yao, Hao-hua, Tan, Lei, Feng, Zi-hao, Li, Jia-ying, Lu, Jun, Pan, Yi-hui, Shu, Guan-nan, Li, Peng-ju, Tang, Yi-ming, Liao, Zhuang-yao, Wei, Jin-huan, Chen, Wei, Guo, Jian-ping, Luo, Jun-hang, Chen, Zhen-hua
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 16.09.2021
Nature Publishing Group
Subjects
13/51
13/89
14/32
14/5
38/77
59/5
631/67/322
631/67/589/1588/1351
64/60
692/53/2422
82/1
82/29
82/58
Angiogenesis
Apoptosis
Cell Biology
Cell migration
Cell proliferation
Clear cell-type renal cell carcinoma
Feedback
Human Genetics
Internal Medicine
Kidney cancer
Medicine
Medicine & Public Health
Metastases
Oncology
Tumorigenesis
Ubiquitination
VHL protein
Online AccessGet full text

Cover

Abstract Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.
AbstractList Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.
Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.
Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.
Abstract Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2α accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2α. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2α protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2α bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2α specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.
Author Yao, Hao-hua
Tan, Lei
Luo, Jun-hang
Liao, Zhuang-yao
Shu, Guan-nan
Li, Peng-ju
Li, Jia-ying
Chen, Wei
Zhang, Li-zhen
Guo, Jian-ping
Tang, Yi-ming
Feng, Zi-hao
Lu, Jun
Wei, Jin-huan
Pan, Yi-hui
Zhang, Ming-xiao
Chen, Zhen-hua
Fu, Liang-min
Author_xml – sequence: 1
  givenname: Ming-xiao
  surname: Zhang
  fullname: Zhang, Ming-xiao
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 2
  givenname: Li-zhen
  surname: Zhang
  fullname: Zhang, Li-zhen
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 3
  givenname: Liang-min
  surname: Fu
  fullname: Fu, Liang-min
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 4
  givenname: Hao-hua
  surname: Yao
  fullname: Yao, Hao-hua
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 5
  givenname: Lei
  surname: Tan
  fullname: Tan, Lei
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Department of Urology, Nanfang Hospital, Southern Medical University
– sequence: 6
  givenname: Zi-hao
  surname: Feng
  fullname: Feng, Zi-hao
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 7
  givenname: Jia-ying
  surname: Li
  fullname: Li, Jia-ying
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 8
  givenname: Jun
  surname: Lu
  fullname: Lu, Jun
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 9
  givenname: Yi-hui
  surname: Pan
  fullname: Pan, Yi-hui
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 10
  givenname: Guan-nan
  surname: Shu
  fullname: Shu, Guan-nan
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 11
  givenname: Peng-ju
  surname: Li
  fullname: Li, Peng-ju
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 12
  givenname: Yi-ming
  surname: Tang
  fullname: Tang, Yi-ming
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 13
  givenname: Zhuang-yao
  surname: Liao
  fullname: Liao, Zhuang-yao
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 14
  givenname: Jin-huan
  surname: Wei
  fullname: Wei, Jin-huan
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 15
  givenname: Wei
  surname: Chen
  fullname: Chen, Wei
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 16
  givenname: Jian-ping
  orcidid: 0000-0002-8158-0101
  surname: Guo
  fullname: Guo, Jian-ping
  email: guojp6@mail.sysu.edu.cn
  organization: Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University
– sequence: 17
  givenname: Jun-hang
  orcidid: 0000-0002-5706-0990
  surname: Luo
  fullname: Luo, Jun-hang
  email: luojunh@mail.sysu.edu.cn
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
– sequence: 18
  givenname: Zhen-hua
  orcidid: 0000-0002-8889-5122
  surname: Chen
  fullname: Chen, Zhen-hua
  email: chenzhh75@mail.sysu.edu.cn
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34321604$$D View this record in MEDLINE/PubMed
BookMark eNp9kdtqFTEUhoNU7G71BbyQgDfejOY4mdwIpfQERYtUb0Mms7JNnUlqMlPw1jfyRfpMZnfXeriQBBJY3_pX_vx7aCemCAg9p-Q1Jbx7UwTlXdcQRhtCtaKNeoRWVKi2kVKLHbQiWpJGM8520V4pV4QQpQl7gna54Iy2RKzQ94tUwhxuAHuAobfuC86wXkY7hxRx8niM7sO7A3zx6ZJiGwd8enbMbn9gl-KcQ7_MUPCcsBvBZuxgHGt7tOP26mx2IabJ4nmZUg5riFBCudOZYLal7lCeosfejgWe3Z_76OPx0eXhaXP-_uTs8OC8cUKJuVFMea8VEDn0vIehA6e6XlFJWOv6ri7fa6F7OmjnfK1L5a1gTJJBcyk930dvt7rXSz_B4KA6sKO5zmGy-ZtJNpi_KzF8Nut0YzohZEd1FXh1L5DT1wXKbKZQNkZthLQUw6RsayCa8Iq-_Ae9SkuuH7OhFKespW1bKbalXE6lZPAPj6HEbCI224hNjdjcRWxUbXrxp42Hll-ZVoBvgVJLcQ359-z_yP4EE9G2tA
CitedBy_id crossref_primary_10_1016_j_gendis_2022_05_037
crossref_primary_10_1155_2022_8928282
crossref_primary_10_1155_2023_4643792
crossref_primary_10_1186_s13046_024_03095_8
crossref_primary_10_1038_s41419_023_05651_0
crossref_primary_10_1097_MD_0000000000037207
crossref_primary_10_1186_s13046_022_02431_0
crossref_primary_10_1186_s40001_023_01422_x
crossref_primary_10_18632_aging_204816
crossref_primary_10_1002_cam4_5723
crossref_primary_10_1016_j_biopha_2022_112801
crossref_primary_10_3389_fgene_2023_1023613
crossref_primary_10_1038_s41417_022_00487_w
crossref_primary_10_18632_aging_204763
crossref_primary_10_2147_IJGM_S409711
crossref_primary_10_1080_21655979_2021_2000122
crossref_primary_10_1016_j_phymed_2023_155072
crossref_primary_10_1186_s11658_022_00385_x
crossref_primary_10_3390_cancers15112903
crossref_primary_10_1080_21655979_2022_2074666
crossref_primary_10_34133_research_0322
crossref_primary_10_1002_advs_202300314
Cites_doi 10.18632/oncotarget.21706
10.1038/nature13311
10.1200/JCO.2017.74.2627
10.1161/01.RES.0000134920.10128.b4
10.1016/j.cell.2018.03.057
10.1186/s12943-019-1064-5
10.1097/01.ju.0000095541.10333.a7
10.1074/jbc.M204733200
10.1038/s41418-019-0381-y
10.1002/hep.27239
10.1016/j.eururo.2019.02.011
10.1038/s41388-018-0250-z
10.1016/j.molcel.2007.01.001
10.2147/OTT.S190239
10.1016/j.ccr.2008.10.016
10.1159/000080345
10.1016/j.cell.2013.06.020
10.1158/0008-5472.CAN-16-0473
10.1158/2159-8290.CD-11-0098
10.1074/jbc.M002740200
10.1038/35017054
10.1002/jcp.26072
10.1038/ki.2009.296
10.1038/cdd.2008.21
10.1210/er.2014-1034
10.1158/1078-0432.CCR-16-0742
10.1038/ncomms13183
10.7150/jca.36822
10.1038/sj.onc.1206373
10.1093/emboj/19.16.4298
10.1038/nature19796
10.18632/oncotarget.19743
10.1038/nrg2521
10.2165/00003495-200767090-00002
10.1128/MCB.25.13.5675-5686.2005
10.1016/j.ccr.2007.02.006
10.1073/pnas.0810571106
10.3389/fonc.2019.00787
10.1093/annonc/mdm411
ContentType Journal Article
Copyright The Author(s) 2021
2021. The Author(s).
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: 2021. The Author(s).
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
NPM
AAYXX
CITATION
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PQEST
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1038/s41388-021-01971-7
DatabaseName Springer Nature Open Access Journals
PubMed
CrossRef
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Research Library Prep

PubMed
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Open Access
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1476-5594
EndPage 5650
ExternalDocumentID 10_1038_s41388_021_01971_7
34321604
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 81902576; 82002684
  funderid: https://doi.org/10.13039/501100001809
– fundername: Medical Scientific Research Foundation of Guangdong Province A2018051
– fundername: China Postdoctoral Science Foundation
  grantid: 236464
  funderid: https://doi.org/10.13039/501100002858
– fundername: Guangdong Basic and Applied Basic Research Foundation 2020A1515111077
– fundername: Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)
  grantid: 2018A030310327; 2017A030313538
  funderid: https://doi.org/10.13039/501100003453
– fundername: ;
– fundername: ;
  grantid: 2018A030310327; 2017A030313538
– fundername: ;
  grantid: 81902576; 82002684
– fundername: ;
  grantid: 236464
GroupedDBID ---
0R~
123
29N
36B
39C
4.4
406
53G
5RE
70F
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWBL
AAZLF
ABAKF
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACZOJ
ADBBV
ADFRT
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFSHS
AGEZK
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C6C
CCPQU
CS3
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAP
EBLON
EBS
EE.
EIOEI
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
L7B
LGEZI
LK8
LOTEE
M1P
M2O
M7P
N9A
NADUK
NQJWS
NXXTH
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
SNX
SNYQT
SOHCF
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TSG
UKHRP
WH7
-Q-
.55
.GJ
2WC
3O-
3V.
AAYZH
ABAWZ
ABDBF
ABEFU
AFFNX
B0M
BAWUL
CAG
COF
DIK
EAD
EBC
EBD
EJD
EMB
EMK
EMOBN
EPL
FIZPM
FRP
M0L
NAO
NPM
OVD
RNS
SV3
TEORI
TR2
TUS
UDS
W2D
X7M
ZXP
~8M
AAYXX
CITATION
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
5PM
ID FETCH-LOGICAL-c474t-727ff97e05db3bed8ec78b715026cb8b8bfb949b1d9ccfed857fa42250d9355f3
IEDL.DBID C6C
ISSN 0950-9232
1476-5594
IngestDate Tue Sep 17 21:11:15 EDT 2024
Sat Aug 17 04:24:43 EDT 2024
Thu Oct 10 18:59:23 EDT 2024
Fri Aug 23 00:59:10 EDT 2024
Wed Oct 23 09:57:52 EDT 2024
Fri Oct 11 20:46:59 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 37
Language English
License 2021. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-727ff97e05db3bed8ec78b715026cb8b8bfb949b1d9ccfed857fa42250d9355f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8889-5122
0000-0002-5706-0990
0000-0002-8158-0101
OpenAccessLink https://doi.org/10.1038/s41388-021-01971-7
PMID 34321604
PQID 2573126166
PQPubID 36330
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8445819
proquest_miscellaneous_2556388903
proquest_journals_2573126166
crossref_primary_10_1038_s41388_021_01971_7
pubmed_primary_34321604
springer_journals_10_1038_s41388_021_01971_7
PublicationCentury 2000
PublicationDate 2021-09-16
PublicationDateYYYYMMDD 2021-09-16
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-16
  day: 16
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAbbrev Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Tanimoto, Makino, Pereira, Poellinger (CR7) 2000; 19
Xu, Wang, Weng, Wei, Qi, Zhang (CR19) 2017; 23
Baba, Hirai, Yamada-Okabe, Hamada, Tabuchi, Kobayashi (CR30) 2003; 22
Gordan, Lal, Dondeti, Letrero, Parekh, Oquendo (CR9) 2008; 14
Liu, Baek, Zhang, Diez, Cole, Semenza (CR37) 2007; 25
Sun, Kraus (CR16) 2015; 36
Turajlic, Xu, Litchfield, Rowan, Chambers, Lopez (CR12) 2018; 173
Raval, Lau, Tran, Sowter, Mandriota, Li (CR10) 2005; 25
Xu, Li, Jin, Han, Sun, Pizzi (CR20) 2019; 18
Ehrlich, Wang, Luo, Xiao, Niewiadomska, Martinez (CR38) 2009; 106
Courtney, Infante, Lam, Figlin, Rini, Brugarolas (CR15) 2018; 36
Zhao, Kong, Sun, Chen, Chen, Zhou (CR21) 2018; 233
Gordan, Bertout, Hu, Diehl, Simon (CR31) 2007; 11
Clark (CR5) 2009; 76
Wang, Li, Xu, Chen, Lu, Shen (CR24) 2020; 11
Escudier (CR2) 2007; 67
Yu, Zhao, He (CR22) 2018; 23
Grampp, Platt, Lauer, Salama, Kranz, Neumann (CR33) 2016; 7
Cockman, Masson, Mole, Jaakkola, Chang, Clifford (CR34) 2000; 275
Ohh, Park, Ivan, Hoffman, Kim, Huang (CR6) 2000; 2
Shen, Beroukhim, Schumacher, Zhou, Chang, Signoretti (CR11) 2011; 1
Wallace, Rizzi, Han, Wehn, Cao, Du (CR14) 2016; 76
Tseng, Moriarity, Gong, Akiyama, Tiwari, Kawakami (CR29) 2014; 512
CR3
Yang, Zhou, Liu, Yan, Yao, Chen (CR27) 2017; 8
Wang, Chen, Lian, Zhang, Yu, Zhang (CR41) 2020; 27
Takeda, Maemura, Imai, Harada, Kawanami, Nojiri (CR32) 2004; 95
Zhao, Du, Cui, Qin, Hu, Wu (CR23) 2018; 37
Wu, Yang, Yang, Fang, Fu, Chen (CR26) 2017; 8
Mercer, Dinger, Mattick (CR17) 2009; 10
Ljungberg, Albiges, Abu-Ghanem, Bensalah, Dabestani, Fernández-Pello (CR1) 2019; 75
Frank, Blute, Cheville, Lohse, Weaver, Leibovich (CR4) 2003; 170
Rankin, Giaccia (CR8) 2008; 15
Isaacs, Jung, Mimnaugh, Martinez, Cuttitta, Neckers (CR35) 2002; 277
Chen, Hill, Christie, Kim, Holloman, Pavia-Jimenez (CR13) 2016; 539
Wang, Yuan, Wang, Yang, Yuan, Ye (CR40) 2014; 60
Li, Zheng, Chen, Cai, Xie (CR28) 2018; 15
Katschinski, Le, Schindler, Thomas, Voss, Wenger (CR36) 2004; 14
Li, Tang, Fu, Wang, Zhu (CR39) 2019; 9
Ulitsky, Bartel (CR18) 2013; 154
Ren, Huang, Weng, Cui, Liang, Li (CR25) 2019; 12
H Wang (1971_CR24) 2020; 11
T Mercer (1971_CR17) 2009; 10
J Zhao (1971_CR23) 2018; 37
E Rankin (1971_CR8) 2008; 15
MY Li (1971_CR39) 2019; 9
F Wang (1971_CR40) 2014; 60
Y Xu (1971_CR20) 2019; 18
RR Raval (1971_CR10) 2005; 25
Y Tseng (1971_CR29) 2014; 512
K Tanimoto (1971_CR7) 2000; 19
I Ulitsky (1971_CR18) 2013; 154
ES Ehrlich (1971_CR38) 2009; 106
W Chen (1971_CR13) 2016; 539
JD Gordan (1971_CR9) 2008; 14
Y Ren (1971_CR25) 2019; 12
S Grampp (1971_CR33) 2016; 7
N Takeda (1971_CR32) 2004; 95
Y Wang (1971_CR41) 2020; 27
T Yang (1971_CR27) 2017; 8
M Baba (1971_CR30) 2003; 22
X Yu (1971_CR22) 2018; 23
L Zhao (1971_CR21) 2018; 233
JD Gordan (1971_CR31) 2007; 11
MD Xu (1971_CR19) 2017; 23
I Frank (1971_CR4) 2003; 170
M Sun (1971_CR16) 2015; 36
W Li (1971_CR28) 2018; 15
B Escudier (1971_CR2) 2007; 67
1971_CR3
B Ljungberg (1971_CR1) 2019; 75
KD Courtney (1971_CR15) 2018; 36
ME Cockman (1971_CR34) 2000; 275
PE Clark (1971_CR5) 2009; 76
Q Wu (1971_CR26) 2017; 8
M Ohh (1971_CR6) 2000; 2
C Shen (1971_CR11) 2011; 1
DM Katschinski (1971_CR36) 2004; 14
S Turajlic (1971_CR12) 2018; 173
JS Isaacs (1971_CR35) 2002; 277
EM Wallace (1971_CR14) 2016; 76
YV Liu (1971_CR37) 2007; 25
References_xml – volume: 8
  start-page: 101865
  year: 2017
  end-page: 75
  ident: CR26
  article-title: Long noncoding RNA PVT1 inhibits renal cancer cell apoptosis by up-regulating Mcl-1
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.21706
  contributor:
    fullname: Chen
– volume: 512
  start-page: 82
  year: 2014
  end-page: 86
  ident: CR29
  article-title: PVT1 dependence in cancer with MYC copy-number increase
  publication-title: Nature.
  doi: 10.1038/nature13311
  contributor:
    fullname: Kawakami
– volume: 36
  start-page: 867
  year: 2018
  end-page: 74
  ident: CR15
  article-title: Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2α antagonist in patients with previously treated advanced clear cell renal cell carcinoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.74.2627
  contributor:
    fullname: Brugarolas
– volume: 95
  start-page: 146
  year: 2004
  end-page: 53
  ident: CR32
  article-title: Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1
  publication-title: Circ Res.
  doi: 10.1161/01.RES.0000134920.10128.b4
  contributor:
    fullname: Nojiri
– volume: 173
  start-page: 581
  year: 2018
  end-page: 594.e512
  ident: CR12
  article-title: Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal
  publication-title: Cell.
  doi: 10.1016/j.cell.2018.03.057
  contributor:
    fullname: Lopez
– volume: 18
  year: 2019
  ident: CR20
  article-title: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-1064-5
  contributor:
    fullname: Pizzi
– volume: 170
  start-page: 2225
  year: 2003
  end-page: 32
  ident: CR4
  article-title: A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma
  publication-title: J Urol
  doi: 10.1097/01.ju.0000095541.10333.a7
  contributor:
    fullname: Leibovich
– volume: 277
  start-page: 29936
  year: 2002
  end-page: 44
  ident: CR35
  article-title: Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M204733200
  contributor:
    fullname: Neckers
– volume: 27
  start-page: 695
  year: 2020
  end-page: 710
  ident: CR41
  article-title: The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-019-0381-y
  contributor:
    fullname: Zhang
– volume: 60
  start-page: 1278
  year: 2014
  end-page: 90
  ident: CR40
  article-title: Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2
  publication-title: Hepatology.
  doi: 10.1002/hep.27239
  contributor:
    fullname: Ye
– volume: 75
  start-page: 799
  year: 2019
  end-page: 810
  ident: CR1
  article-title: European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
  publication-title: Eur Urol.
  doi: 10.1016/j.eururo.2019.02.011
  contributor:
    fullname: Fernández-Pello
– volume: 37
  start-page: 4094
  year: 2018
  end-page: 109
  ident: CR23
  article-title: LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer
  publication-title: Oncogene.
  doi: 10.1038/s41388-018-0250-z
  contributor:
    fullname: Wu
– volume: 25
  start-page: 207
  year: 2007
  end-page: 17
  ident: CR37
  article-title: RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2007.01.001
  contributor:
    fullname: Semenza
– volume: 12
  start-page: 2563
  year: 2019
  end-page: 75
  ident: CR25
  article-title: LncRNA PVT1 promotes proliferation, invasion and epithelial-mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p
  publication-title: Onco Targets Ther.
  doi: 10.2147/OTT.S190239
  contributor:
    fullname: Li
– volume: 14
  start-page: 435
  year: 2008
  end-page: 46
  ident: CR9
  article-title: HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccr.2008.10.016
  contributor:
    fullname: Oquendo
– volume: 14
  start-page: 351
  year: 2004
  end-page: 60
  ident: CR36
  article-title: Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization
  publication-title: Cell Physiol Biochem.
  doi: 10.1159/000080345
  contributor:
    fullname: Wenger
– volume: 154
  start-page: 26
  year: 2013
  end-page: 46
  ident: CR18
  article-title: lincRNAs: genomics, evolution, and mechanisms
  publication-title: Cell.
  doi: 10.1016/j.cell.2013.06.020
  contributor:
    fullname: Bartel
– volume: 76
  start-page: 5491
  year: 2016
  end-page: 5500
  ident: CR14
  article-title: A small-molecule antagonist of HIF2α is efficacious in preclinical models of renal cell carcinoma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-0473
  contributor:
    fullname: Du
– volume: 1
  start-page: 222
  year: 2011
  end-page: 35
  ident: CR11
  article-title: Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-11-0098
  contributor:
    fullname: Signoretti
– volume: 275
  start-page: 25733
  year: 2000
  end-page: 41
  ident: CR34
  article-title: Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M002740200
  contributor:
    fullname: Clifford
– volume: 2
  start-page: 423
  year: 2000
  end-page: 7
  ident: CR6
  article-title: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
  publication-title: Nat Cell Biol
  doi: 10.1038/35017054
  contributor:
    fullname: Huang
– volume: 233
  start-page: 4044
  year: 2018
  end-page: 55
  ident: CR21
  article-title: LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448
  publication-title: J Cell Physiol.
  doi: 10.1002/jcp.26072
  contributor:
    fullname: Zhou
– volume: 76
  start-page: 939
  year: 2009
  end-page: 45
  ident: CR5
  article-title: The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy
  publication-title: Kidney Int.
  doi: 10.1038/ki.2009.296
  contributor:
    fullname: Clark
– volume: 23
  start-page: 48
  year: 2018
  end-page: 54
  ident: CR22
  article-title: Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis
  publication-title: J Buon.
  contributor:
    fullname: He
– volume: 15
  start-page: 678
  year: 2008
  end-page: 85
  ident: CR8
  article-title: The role of hypoxia-inducible factors in tumorigenesis
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2008.21
  contributor:
    fullname: Giaccia
– volume: 36
  start-page: 25
  year: 2015
  end-page: 64
  ident: CR16
  article-title: From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease
  publication-title: Endocr Rev.
  doi: 10.1210/er.2014-1034
  contributor:
    fullname: Kraus
– volume: 23
  start-page: 2071
  year: 2017
  end-page: 80
  ident: CR19
  article-title: A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-0742
  contributor:
    fullname: Zhang
– ident: CR3
– volume: 7
  year: 2016
  ident: CR33
  article-title: Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
  publication-title: Nat Commun.
  doi: 10.1038/ncomms13183
  contributor:
    fullname: Neumann
– volume: 11
  start-page: 2737
  year: 2020
  end-page: 48
  ident: CR24
  article-title: The prognostic value of miRNA-18a-5p in clear cell renal cell carcinoma and its function via the miRNA-18a-5p/HIF1A/PVT1 pathway
  publication-title: J Cancer.
  doi: 10.7150/jca.36822
  contributor:
    fullname: Shen
– volume: 15
  start-page: 7855
  year: 2018
  end-page: 63
  ident: CR28
  article-title: Knockdown of long non-coding RNA PVT1 induces apoptosis and cell cycle arrest in clear cell renal cell carcinoma through the epidermal growth factor receptor pathway
  publication-title: Oncol Lett.
  contributor:
    fullname: Xie
– volume: 22
  start-page: 2728
  year: 2003
  end-page: 38
  ident: CR30
  article-title: Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor
  publication-title: Oncogene.
  doi: 10.1038/sj.onc.1206373
  contributor:
    fullname: Kobayashi
– volume: 19
  start-page: 4298
  year: 2000
  end-page: 309
  ident: CR7
  article-title: Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein
  publication-title: EMBO J
  doi: 10.1093/emboj/19.16.4298
  contributor:
    fullname: Poellinger
– volume: 539
  start-page: 112
  year: 2016
  end-page: 7
  ident: CR13
  article-title: Targeting renal cell carcinoma with a HIF-2 antagonist
  publication-title: Nature.
  doi: 10.1038/nature19796
  contributor:
    fullname: Pavia-Jimenez
– volume: 8
  start-page: 85353
  year: 2017
  end-page: 67
  ident: CR27
  article-title: lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.19743
  contributor:
    fullname: Chen
– volume: 10
  start-page: 155
  year: 2009
  end-page: 9
  ident: CR17
  article-title: Long non-coding RNAs: insights into functions
  publication-title: Nat Rev Genet.
  doi: 10.1038/nrg2521
  contributor:
    fullname: Mattick
– volume: 67
  start-page: 1257
  year: 2007
  end-page: 64
  ident: CR2
  article-title: Advanced renal cell carcinoma: current and emerging management strategies
  publication-title: Drugs.
  doi: 10.2165/00003495-200767090-00002
  contributor:
    fullname: Escudier
– volume: 25
  start-page: 5675
  year: 2005
  end-page: 86
  ident: CR10
  article-title: Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.25.13.5675-5686.2005
  contributor:
    fullname: Li
– volume: 11
  start-page: 335
  year: 2007
  end-page: 47
  ident: CR31
  article-title: HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.02.006
  contributor:
    fullname: Simon
– volume: 106
  start-page: 20330
  year: 2009
  end-page: 5
  ident: CR38
  article-title: Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0810571106
  contributor:
    fullname: Martinez
– volume: 9
  start-page: 787
  year: 2019
  ident: CR39
  article-title: Regulatory mechanisms and clinical applications of the long non-coding RNA PVT1 in cancer treatment
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.00787
  contributor:
    fullname: Zhu
– volume: 37
  start-page: 4094
  year: 2018
  ident: 1971_CR23
  publication-title: Oncogene.
  doi: 10.1038/s41388-018-0250-z
  contributor:
    fullname: J Zhao
– volume: 23
  start-page: 2071
  year: 2017
  ident: 1971_CR19
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-0742
  contributor:
    fullname: MD Xu
– volume: 19
  start-page: 4298
  year: 2000
  ident: 1971_CR7
  publication-title: EMBO J
  doi: 10.1093/emboj/19.16.4298
  contributor:
    fullname: K Tanimoto
– volume: 539
  start-page: 112
  year: 2016
  ident: 1971_CR13
  publication-title: Nature.
  doi: 10.1038/nature19796
  contributor:
    fullname: W Chen
– volume: 277
  start-page: 29936
  year: 2002
  ident: 1971_CR35
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M204733200
  contributor:
    fullname: JS Isaacs
– volume: 12
  start-page: 2563
  year: 2019
  ident: 1971_CR25
  publication-title: Onco Targets Ther.
  doi: 10.2147/OTT.S190239
  contributor:
    fullname: Y Ren
– volume: 154
  start-page: 26
  year: 2013
  ident: 1971_CR18
  publication-title: Cell.
  doi: 10.1016/j.cell.2013.06.020
  contributor:
    fullname: I Ulitsky
– volume: 23
  start-page: 48
  year: 2018
  ident: 1971_CR22
  publication-title: J Buon.
  contributor:
    fullname: X Yu
– ident: 1971_CR3
  doi: 10.1093/annonc/mdm411
– volume: 8
  start-page: 85353
  year: 2017
  ident: 1971_CR27
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.19743
  contributor:
    fullname: T Yang
– volume: 18
  year: 2019
  ident: 1971_CR20
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-1064-5
  contributor:
    fullname: Y Xu
– volume: 22
  start-page: 2728
  year: 2003
  ident: 1971_CR30
  publication-title: Oncogene.
  doi: 10.1038/sj.onc.1206373
  contributor:
    fullname: M Baba
– volume: 76
  start-page: 5491
  year: 2016
  ident: 1971_CR14
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-0473
  contributor:
    fullname: EM Wallace
– volume: 11
  start-page: 2737
  year: 2020
  ident: 1971_CR24
  publication-title: J Cancer.
  doi: 10.7150/jca.36822
  contributor:
    fullname: H Wang
– volume: 15
  start-page: 678
  year: 2008
  ident: 1971_CR8
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2008.21
  contributor:
    fullname: E Rankin
– volume: 173
  start-page: 581
  year: 2018
  ident: 1971_CR12
  publication-title: Cell.
  doi: 10.1016/j.cell.2018.03.057
  contributor:
    fullname: S Turajlic
– volume: 14
  start-page: 351
  year: 2004
  ident: 1971_CR36
  publication-title: Cell Physiol Biochem.
  doi: 10.1159/000080345
  contributor:
    fullname: DM Katschinski
– volume: 1
  start-page: 222
  year: 2011
  ident: 1971_CR11
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-11-0098
  contributor:
    fullname: C Shen
– volume: 95
  start-page: 146
  year: 2004
  ident: 1971_CR32
  publication-title: Circ Res.
  doi: 10.1161/01.RES.0000134920.10128.b4
  contributor:
    fullname: N Takeda
– volume: 170
  start-page: 2225
  year: 2003
  ident: 1971_CR4
  publication-title: J Urol
  doi: 10.1097/01.ju.0000095541.10333.a7
  contributor:
    fullname: I Frank
– volume: 15
  start-page: 7855
  year: 2018
  ident: 1971_CR28
  publication-title: Oncol Lett.
  contributor:
    fullname: W Li
– volume: 9
  start-page: 787
  year: 2019
  ident: 1971_CR39
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.00787
  contributor:
    fullname: MY Li
– volume: 67
  start-page: 1257
  year: 2007
  ident: 1971_CR2
  publication-title: Drugs.
  doi: 10.2165/00003495-200767090-00002
  contributor:
    fullname: B Escudier
– volume: 106
  start-page: 20330
  year: 2009
  ident: 1971_CR38
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0810571106
  contributor:
    fullname: ES Ehrlich
– volume: 27
  start-page: 695
  year: 2020
  ident: 1971_CR41
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-019-0381-y
  contributor:
    fullname: Y Wang
– volume: 2
  start-page: 423
  year: 2000
  ident: 1971_CR6
  publication-title: Nat Cell Biol
  doi: 10.1038/35017054
  contributor:
    fullname: M Ohh
– volume: 14
  start-page: 435
  year: 2008
  ident: 1971_CR9
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccr.2008.10.016
  contributor:
    fullname: JD Gordan
– volume: 10
  start-page: 155
  year: 2009
  ident: 1971_CR17
  publication-title: Nat Rev Genet.
  doi: 10.1038/nrg2521
  contributor:
    fullname: T Mercer
– volume: 8
  start-page: 101865
  year: 2017
  ident: 1971_CR26
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.21706
  contributor:
    fullname: Q Wu
– volume: 512
  start-page: 82
  year: 2014
  ident: 1971_CR29
  publication-title: Nature.
  doi: 10.1038/nature13311
  contributor:
    fullname: Y Tseng
– volume: 36
  start-page: 25
  year: 2015
  ident: 1971_CR16
  publication-title: Endocr Rev.
  doi: 10.1210/er.2014-1034
  contributor:
    fullname: M Sun
– volume: 275
  start-page: 25733
  year: 2000
  ident: 1971_CR34
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M002740200
  contributor:
    fullname: ME Cockman
– volume: 75
  start-page: 799
  year: 2019
  ident: 1971_CR1
  publication-title: Eur Urol.
  doi: 10.1016/j.eururo.2019.02.011
  contributor:
    fullname: B Ljungberg
– volume: 7
  year: 2016
  ident: 1971_CR33
  publication-title: Nat Commun.
  doi: 10.1038/ncomms13183
  contributor:
    fullname: S Grampp
– volume: 36
  start-page: 867
  year: 2018
  ident: 1971_CR15
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.74.2627
  contributor:
    fullname: KD Courtney
– volume: 233
  start-page: 4044
  year: 2018
  ident: 1971_CR21
  publication-title: J Cell Physiol.
  doi: 10.1002/jcp.26072
  contributor:
    fullname: L Zhao
– volume: 25
  start-page: 5675
  year: 2005
  ident: 1971_CR10
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.25.13.5675-5686.2005
  contributor:
    fullname: RR Raval
– volume: 11
  start-page: 335
  year: 2007
  ident: 1971_CR31
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.02.006
  contributor:
    fullname: JD Gordan
– volume: 25
  start-page: 207
  year: 2007
  ident: 1971_CR37
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2007.01.001
  contributor:
    fullname: YV Liu
– volume: 76
  start-page: 939
  year: 2009
  ident: 1971_CR5
  publication-title: Kidney Int.
  doi: 10.1038/ki.2009.296
  contributor:
    fullname: PE Clark
– volume: 60
  start-page: 1278
  year: 2014
  ident: 1971_CR40
  publication-title: Hepatology.
  doi: 10.1002/hep.27239
  contributor:
    fullname: F Wang
SSID ssj0007902
Score 2.5441396
Snippet Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important...
Abstract Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 5639
SubjectTerms 13/51
13/89
14/32
14/5
38/77
59/5
631/67/322
631/67/589/1588/1351
64/60
692/53/2422
82/1
82/29
82/58
Angiogenesis
Apoptosis
Cell Biology
Cell migration
Cell proliferation
Clear cell-type renal cell carcinoma
Feedback
Human Genetics
Internal Medicine
Kidney cancer
Medicine
Medicine & Public Health
Metastases
Oncology
Tumorigenesis
Ubiquitination
VHL protein
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BKygXBAuUQEFG4gZW7dixkxMqVVcLUlerqkW9RYljiwo2KU0WiSv_iD_Cb2LsJFstFSiXRM6n32T87Bn7Aby2No25k5JyUTEqjf-llDCUc5VJo1Rahrkwx3M1O5Mfz5PzYcCtHdIqR58YHHXVGD9Gvo-mJTjSfaXeXX6jXjXKR1cHCY3bsB1z6cO02--P5ouTtS_WfdYh8ghGkcrEw7QZJtL9Ft03WolPUUCaoznVm03TDb55M23yr9hpaJKmD-D-wCXJQQ_-Q7hl6wnc6dUlf0xg53AUc5vA3eMhhv4Ifi5CntZ3Sxy2XGVhvpCrXpAeISKNI19rczI_IItPp5wUdUVmH6bx718kJLV7dSzbkq4hxutNED_uj5f71wi7xksT1c2yIN1q6avPu9KLNtxnabsCuSgePoaz6dHp4YwOSgzUSC07iiTHuUxbllSlKG2VWqMRRSSTsTJlipsrM5mVvMqMcVieaFdIdBWs8uu3O_EEtuqmtk-BVCoxZZUwZYtCCm2RMBRO41XYc8OuE4vgzQhCftkvuJGHQLlI8x6yHCHLA2S5jmBvxCkffr42vzaVCF6ti7HCfUUUtW1W_pwEPU-aMRHBbg_r-nF-ri1XTEagNwBfn-CX5N4sqS8-h6W5UykT5FgRvB1N4_q1_v0Vz_7_Fc_hXhzMNKNc7cFWd7WyL5AKdeXLwd7_ANobB5I
  priority: 102
  providerName: ProQuest
Title Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis
URI https://link.springer.com/article/10.1038/s41388-021-01971-7
https://www.ncbi.nlm.nih.gov/pubmed/34321604
https://www.proquest.com/docview/2573126166
https://www.proquest.com/docview/2556388903/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC8445819
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD5im7i8ICiXBUZlJN7AIk4c23kc0aqCtKqaNtS3yHFsMUGTaU2ReOUf8Uf4TRw7aVEZPKBIUSI7juPPPv4cnwvAK2tVwhznlKV1TLnxQ0qkhjImcm6EUFWwhTmdiekF_7DIFoObHG8Ls7N_n6q3KxSyiKVXJEAyIhmVe3CQMRH7HlyIYit1Za9fiIwhpkhaksFA5u9l7E5CN5jlTQXJP3ZJw-QzeQD3B9ZIjnuYH8It24zgdh9H8tsI7habsG0juHM67JY_gu_zoJH11RKHc1SlzWdy3YeeRzBI68iXxpzNjsn84zkjuqnJ9P0k-fmDBPV1HwfLrkjXEuMjSxD_hx8f99UIl8YHIWrapSbdeunDa3mhebkK5Sxtp5F14u1juJicnBdTOsRcoIZL3lGkM87l0sZZXaWVrZU1EvFC2pgIUyk8XJXzvGJ1bozD9Ew6zVEoxLX31O7SJ7DftI09BFKLzFR1FgurNU-lRWqgncSncI2Gi6Q4gtcbEMqr3rVGGbbEU1X2kJUIWRkgK2UERxucymGYrUqUNynDNaAQEbzcJmOD-4bQjW3XPk-GMkblcRrB0x7W7eu8VS32JR6B3AF8m8E7395NaS4_BSfcivMM2VQEbzZd43e1_v0Vz_4v-3O4l4Rum1MmjmC_u17bF0iCumoMe3Ih8awKNoaDdyez-dk4jIhfMlUCaQ
link.rule.ids 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,41153,42222,43343,43612,43838,51609,74100,74369,74657
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFL2CIRgvCApsgQFG4g2sxbFjJ09oqqg6WKsJdWhvUeLYYoImY0mReOUf8Uf4TVw7SasygfKSyPmwfW6uj-1rH4BXxiQRs0JQxsuQCu1-Kck1ZUymQkuZFH4tzGwup2fi_Xl83g-4NX1Y5eATvaMua-3GyA_RtDhDui_l28tv1KlGudnVXkLjJtwSHNtqt1J8vAnxUF3MIbKIkCKRifpFMyFPDht03mgjLkABSY5iVG03TNfY5vWgyb9mTn2DNLkP93omSY466B_ADVON4HanLfljBLvjQcptBHdm_Qz6Q_h56qO0vhtisd0qcv2FXHVy9AgQqS35WumP8yNy-mnBSF6VZHo8iX7_Ij6k3WljmYa0NdFObYK4UX983GXDn2onTFTVy5y0q6WrPOdILxr_nqVpc2SiePkIzibvFuMp7XUYqBZKtBQpjrWpMmFcFrwwZWK0QgyRSkZSFwketkhFWrAy1dpieqxsLtBRhKXbvd3yx7BT1ZXZB1LKWBdlHEqT54Irg3Qhtwqfwn4bdpzCAF4PIGSX3XYbmZ8m50nWQZYhZJmHLFMBHAw4Zf2v12QbQwng5ToZK9xVRF6ZeuXuidHvJGnIA9jrYF1_zq20ZTIUAagtwNc3uA25t1Oqi89-Y-5EiBgZVgBvBtPYZOvfpXjy_1K8gN3pYnaSnRzPPzyFu5E32ZQyeQA77dXKPENS1BbPveX_AZlzCOQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFL2CITZeEJSvwAAj8QZW7cSxkyc0FaoOWFWhDe0tShxbTKzJWFIkXvlH_BF-E9dO0qpMoL6kcpImPjfXJ73HPgAvjUlCboWgPCoZFdo9UjLSlHOZCi1lUvi5MEdzOTsR70_j017_1PSyyiEn-kRd1tr9Rz7G0Io40n0px7aXRSzeTt9cfKPOQcpVWns7jetwA0dF6SI8mWzkHqrTHyKjYBRJTdhPoGFRMm4wkWO8OLECEh7FqdoepK4wz6sCyr-qqH5wmt6B2z2rJAddGNyFa6Yawc3OZ_LHCPYmg63bCHaP-mr6Pfi58Iqt74ZYHMOKXH8ll501PYJFakvOK_1pfkAWn485yauSzA6n4e9fxMvbnU-WaUhbE-2cJ4irAODh7jL8pnYmRVW9zEm7WrrOc0n1rPHnWZo2R1aKX-_DyfTd8WRGe08GqoUSLUW6Y22qDIvLIipMmRitEE-klaHURYIfW6QiLXiZam2xPVY2F5g0WOlWcrfRA9ip6so8AlLKWBdlzKTJcxEpg9QhtwqPwnc4fIliAbwaQMguuqU3Ml8yj5KsgyxDyDIPWaYC2B9wyvrHsMk2QRPAi3UzdrjriLwy9crtE2MOSlIWBfCwg3X9c27WLZdMBKC2AF_v4Bbn3m6pzr74RboTIWJkWwG8HkJjc1n_vovH_7-L57CLQZ99PJx_eAK3Qh-xKeVyH3bay5V5ivyoLZ75wP8DMEENIg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Positive+feedback+regulation+of+lncRNA+PVT1+and+HIF2%CE%B1+contributes+to+clear+cell+renal+cell+carcinoma+tumorigenesis+and+metastasis&rft.jtitle=Oncogene&rft.au=Zhang%2C+Ming-xiao&rft.au=Zhang%2C+Li-zhen&rft.au=Fu%2C+Liang-min&rft.au=Yao%2C+Hao-hua&rft.date=2021-09-16&rft.pub=Nature+Publishing+Group+UK&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=40&rft.issue=37&rft.spage=5639&rft.epage=5650&rft_id=info:doi/10.1038%2Fs41388-021-01971-7&rft.externalDocID=10_1038_s41388_021_01971_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon